Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5151075 | 0.85 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL1730047 | 0.83 | — | — | |
| SCHEMBL6360345 | 0.83 | ALDH1A1 (0.62) | ALDH1A1 | |
| SCHEMBL2801955 | 0.79 | ALDH1A1 (0.56) | ALDH1A1 | |
| Pentaerythritol Tetranitrate SCHEMBL920358 | 0.77 | ALDH1A1 (1.00) | ALDH1A1 | |
| Pentaerythritol Tetranitrate SCHEMBL37177 | 0.77 | ALDH1A1 (1.00) | ALDH1A1 | |
| SCHEMBL2802430 | 0.75 | ALDH1A1 (0.52) | ALDH1A1 | |
| Pentaerythritol Tetranitrate SCHEMBL5940085 | 0.74 | ALDH1A1 (0.94) | ALDH1A1 | |
| SCHEMBL2220993 | 0.72 | ALDH1A1 (0.62) | ALDH1A1 | |
| SCHEMBL7759159 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010005687-A1 | COMPOSITIONS COMPRISING NITRIC OXIDE OR NITRIC OXIDE DONORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR TRAUMA | UNIVERSITY OF ALABAMA HUNTSVILLE (US) | 2010-01-14 | — | — | WO | claimed |
| WO-2009152479-A1 | COMPOSITIONS COMPRISING NITRIC OXIDE OR NITRIC OXIDE DONORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OF TRAUMA | UNIVERSITY OF ALABAMA HUNTSVILLE (US) | 2009-12-17 | — | — | WO | claimed |
| JP-2001517697-A | — | — | 2001-10-09 | — | — | JP | claimed |
| WO-2001028534-A2 | REDUCTION MODERATORS | ALPHARMA-ISIS GMBH & CO. KG (DE) | 2001-04-26 | — | — | WO | claimed |
| EP-1087926-A2 | ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS | Alpharma-Isis GmbH & Co. KG (DE) | 2001-04-04 | — | — | EP | claimed |
| EP-1019038-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME | RHODES, John (GB) | 2000-07-19 | — | — | EP | claimed |
| WO-1999067430-A2 | ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS | ALPHARMA-ISIS GMBH & CO. KG (DE) | 1999-12-29 | — | — | WO | claimed |
| WO-1999016436-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME | RHODES JOHN (GB) | 1999-04-08 | — | — | WO | claimed |
| US-5504117-A | Pharmacologic preparation for the treatment of anal disorders | NEPTUNE PHARMACEUTICAL CORPORATION (US) | 1996-04-02 | — | — | US | claimed |
| US-9220744-B2 | Compositions and methods for treating diseases | LUMEN THERAPEUTICS, LLC (US) | 2015-12-29 | — | — | US | disclosed |
| US-20140342986-A1 | Compositions and methods for treating diseases | LUMEN THERAPEUTICS, LLC (US) | 2014-11-20 | — | — | US | disclosed |
| US-20110124584-A1 | Compositions and methods for treating diseases | ROTHBARD JONATHAN B | 2011-05-26 | — | — | US | disclosed |
| US-7820626-B2 | such as vulvodynia via comprising administering polyarginine; for treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing agents | LUMEN THERAPEUTICS, LLC (US) | 2010-10-26 | — | — | US | disclosed |
| WO-2010005687-A1 | COMPOSITIONS COMPRISING NITRIC OXIDE OR NITRIC OXIDE DONORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR TRAUMA | UNIVERSITY OF ALABAMA HUNTSVILLE (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-1999016436-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME | RHODES JOHN (GB) | 1999-04-08 | — | — | WO | disclosed |
| WO-1998015521-A1 | NEW PENTAERYTHRITOL DERIVATIVES, THEIR PRODUCTION AND USE AND INTERMEDIATES FOR THEIR SYNTHESIS | ISIS PHARMA GMBH (DE) | 1998-04-16 | — | — | WO | disclosed |
| EP-0752858-A1 | PHARMACEUTICAL PREPARATIONS AND MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF ENDOTHELIAL DYSFUNCTION | ISIS PHARMA GMBH (DE) | 1997-01-15 | — | — | EP | disclosed |
| US-5504117-A | Pharmacologic preparation for the treatment of anal disorders | NEPTUNE PHARMACEUTICAL CORPORATION (US) | 1996-04-02 | — | — | US | disclosed |
| WO-1995026725-A1 | PHARMACEUTICAL PREPARATIONS AND MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF ENDOTHELIAL DYSFUNCTION | ISIS PHARMA GMBH (DE) | 1995-10-12 | — | — | WO | disclosed |
| US-4118414-A | PROPELLANTS | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-10-03 | — | — | US | disclosed |